Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition: Breast Cancer Intervention: Drug: metronomic oral vinorelbine plus anlotinib Sponsor: Yan Xue Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials